Announced on its homepage: “€18M to turn technology into products Biomemory raises €18 million from Bpifrance, Crédit Mutuel Innovation, Blast and other investors.”.
Observed on the company’s website; business claims are not independently verified.
Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Data economy, meet DNA computing
We began by storing data in synthetic DNA. Now we’re creating a whole new DNA-based computing platform.
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
Seen November 2026 · 1 capture · latest observed messagingMolecular IT, industrialized
Molecular IT: Biomemory stores data in synthetic DNA. DNA Shield keeps your irreplaceable data offline and sovereign, up to 150 years. Early Access open.